BRIEF-Oncternal Provides Business Update And Announces First Quarter 2021 Financial Results
BRIEF-Oncternal Provides Business Update And Announces First Quarter 2021 Financial Results
Brief-Oncternal提供业务更新并宣布2021年第一季度财务业绩
May 6 (Reuters) - Oncternal Therapeutics Inc :
* ONCTERNAL PROVIDES BUSINESS UPDATE AND ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.12
* ONCTERNAL THERAPEUTICS - BELIEVE CURRENT CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS INTO 2023
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* ONCTERNAL PROVIDES BUSINESS UPDATE AND ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.12
* ONCTERNAL THERAPEUTICS - BELIEVE CURRENT CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS INTO 2023
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
May 6 (Reuters) - Oncternal Therapeutics Inc :
* ONCTERNAL PROVIDES BUSINESS UPDATE AND ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.12
* ONCTERNAL THERAPEUTICS - BELIEVE CURRENT CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS INTO 2023
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透5月6日电-Oncternal Treateutics Inc:*ONCTERNAL提供业务更新并宣布2021年第一季度财务业绩*第一季度每股亏损0.12美元*ONCTERNAL Treeutics-相信目前的现金和现金等价物将足以为2023年的运营提供资金Eikon的源文本:进一步的公司报道:(Reurs.Briefs@thomsonreurs.com;)
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
风险及免责提示
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
知道了
风险及免责提示
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!